Transcripts

Abbott Laboratories (ABT) earnings call transcripts

Earnings call transcripts for Abbott Laboratories, with a summary, the guidance given, and what analysts pressed on.

  • Q3 2026 earnings call

    Management framed the nutrition separation as a strategic growth move, while acknowledging near-term diabetes pricing and EP order headwinds behind a more cautious outlook.

    Oct 21, 2026Positive0.45